4.1 Article

Hepatoma Cell Growth Inhibition by Inducing Apoptosis with Polysaccharide Isolated from Turkey Tail Medicinal Mushroom, Trametes versicolor (L.: Fr.) Lloyd (Aphyllophoromycetideae)

Journal

INTERNATIONAL JOURNAL OF MEDICINAL MUSHROOMS
Volume 12, Issue 3, Pages 257-263

Publisher

BEGELL HOUSE INC
DOI: 10.1615/IntJMedMushr.v12.i3.40

Keywords

Turkey Tail mushroom; Trametes (=Coriolus) versicolor; medicinal mushrooms; polysaccharide; anti-tumor; apoptosis; human hepatoma cancer

Funding

  1. National Science Fund for Fostering Talents in Basic Science
  2. Nation Science Education Base at Fudan University [J0630643]

Ask authors/readers for more resources

The Trametes (=Coriolus) versicolor polysaccharide (CVP) is well known as an antitumor drug in clinical applications. Although recent studies have demonstrated that CVPs can inhibit the proliferation of cancer cells in vitro and in vivo, different purity levels of CVPs have a different affect on various cancer cells. In this study, crude CVPs were extracted and purified from T versicolor dry fruit bodies by hot-water extraction, ethanol precipitation, and phenol-vitriolic colorimetry. The in vitro cytotoxic activities of CVPs were examined on the human hepatoma cancer (QGY) cell lines by using an MTT assay. The cell cycle and cell death (apoptosis) of QGY cells were investigated by flow cytometry. The expression of genes involved in the apoptosis process, such as p.53, Bc1-2, and Fas, was also studied using reverse transcriptase-polymerase chain reaction (RT-PCR) techniques. These results showed that CVPs inhibited the proliferation of QGY in low concentrations (<20 mg/L) and the IC50 value was 4.25 mg/L. Changes that are characteristic of apoptosis, such as a found trapezoidal belt with DNA, were observed in the QGY cells treated with CVPs. There was a significant decrease in the expression of the cell cycle-related genes (p53, Bc1-2, and Fas) in these cells following treatment with CVPs. These results thus indicate that CVPs can be a potential candidate to ameliorate toxic effects when used in cancer therapy.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.1
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available